BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.
暂无分享,去创建一个
B. Esterni | P. Viens | R. Largillier | J. Raoul | J. Seitz | A. Gonçalves | O. Turrini | L. Dahan | M. Gilabert | M. Giovannini | M. Gasmi | R. Lamy | E. François | L. Moureau-Zabotto | D. Genre | X. Tchiknavorian | H. Perrier | J. Delpero | D. Ré